Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Share Price Matters!

<< Previous

Bullboard Posts

Next >>

Post by Gorf79on Apr 23, 2022 10:19am

273 Views

Post# 34626074

Share Price Matters!

It is a public company after all that funds itself entirely through dilutive financings. Share price matters.

Bencro,

With this is mind and a coffee in hand I have run a market cap analysis, using moderately detailed but now stale financials and the most recent and equally stale shareholder newsletter to determine my inputs.

Using a very conservative 30% probability of FDA success I have derived a value today of $3.46/ share.

What do you think?

I’d lay that out in bullet points for you but I know you have a phobia about things being presented in a coherent and logical format.

<< Previous

Bullboard Posts

Next >>

Dollar Tree CEO Rick Dreiling steps down as discount retailer struggles